350 related articles for article (PubMed ID: 28085888)
1. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A
Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815
[TBL] [Abstract][Full Text] [Related]
3. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
4. Performance of hemodialysis with novel medium cut-off dialyzers.
Kirsch AH; Lyko R; Nilsson LG; Beck W; Amdahl M; Lechner P; Schneider A; Wanner C; Rosenkranz AR; Krieter DH
Nephrol Dial Transplant; 2017 Jan; 32(1):165-172. PubMed ID: 27587605
[TBL] [Abstract][Full Text] [Related]
5. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
6. A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study.
Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho Y; Wong M; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
Blood Purif; 2020; 49(4):468-478. PubMed ID: 31968346
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of medium cut-off dialyzers and comparison with high-flux dialyzers in patients on maintenance hemodialysis: A systematic review and meta-analysis.
Yang J; Ke G; Liao Y; Guo Y; Gao X
Ther Apher Dial; 2022 Aug; 26(4):756-768. PubMed ID: 34773675
[TBL] [Abstract][Full Text] [Related]
8. High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration.
Maduell F; Rodas L; Broseta JJ; Gómez M; Xipell Font M; Molina A; Montagud-Marrahi E; Guillén E; Arias-Guillén M; Fontseré N; Vera Rivera M; Rico N
Artif Organs; 2019 Oct; 43(10):1014-1021. PubMed ID: 31038748
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.
Willy K; Hulko M; Storr M; Speidel R; Gauss J; Schindler R; Zickler D
Artif Organs; 2017 Sep; 41(9):803-809. PubMed ID: 28524237
[TBL] [Abstract][Full Text] [Related]
10. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
[TBL] [Abstract][Full Text] [Related]
11. Medium Cut-Off Dialyzer versus Eight Hemodiafiltration Dialyzers: Comparison Using a Global Removal Score.
Maduell F; Rodas L; Broseta JJ; Gomez M; Xipell M; Guillen E; Montagud-Marrahi E; Arias-Guillén M; Fontseré N; Vera M; Rico N
Blood Purif; 2019; 48(2):167-174. PubMed ID: 30943486
[TBL] [Abstract][Full Text] [Related]
12. Effects of Medium Cut-Off Versus High-Flux Hemodialysis Membranes on Biomarkers: A Systematic Review and Meta-Analysis.
Kandi M; Brignardello-Petersen R; Couban R; Wu C; Nesrallah G
Can J Kidney Health Dis; 2022; 9():20543581211067090. PubMed ID: 35070336
[TBL] [Abstract][Full Text] [Related]
13. Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules.
Kirsch AH; Rosenkranz AR; Lyko R; Krieter DH
Contrib Nephrol; 2017; 191():158-167. PubMed ID: 28910799
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer: A Randomized Controlled Trial.
Weiner DE; Falzon L; Skoufos L; Bernardo A; Beck W; Xiao M; Tran H
Clin J Am Soc Nephrol; 2020 Sep; 15(9):1310-1319. PubMed ID: 32843372
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients.
Lim JH; Park Y; Yook JM; Choi SY; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Cho JH
Sci Rep; 2020 May; 10(1):7780. PubMed ID: 32385307
[TBL] [Abstract][Full Text] [Related]
16. Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.
Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho YJ; Wong MG; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Darssan D; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
BMC Nephrol; 2018 Apr; 19(1):89. PubMed ID: 29665795
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial.
Belmouaz M; Bauwens M; Hauet T; Bossard V; Jamet P; Joly F; Chikhi E; Joffrion S; Gand E; Bridoux F
Nephrol Dial Transplant; 2020 Feb; 35(2):328-335. PubMed ID: 31578564
[TBL] [Abstract][Full Text] [Related]
18. Effect of Membrane Permeability on Cardiovascular Risk Factors and β2m Plasma Levels in Patients on Long-Term Haemodialysis: A Randomised Crossover Trial.
Chazot C; Kirchgessner J; Pham J; Vo-Van C; Lorriaux C; Hurot JM; Zaoui E; Grassmann A; Jean G; Marcelli D
Nephron; 2015; 129(4):269-75. PubMed ID: 25825336
[TBL] [Abstract][Full Text] [Related]
19. Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling.
Catar R; Moll G; Kamhieh-Milz J; Luecht C; Chen L; Zhao H; Ernst L; Willy K; Girndt M; Fiedler R; Witowski J; Morawietz H; Ringdén O; Dragun D; Eckardt KU; Schindler R; Zickler D
Front Immunol; 2021; 12():774052. PubMed ID: 34858433
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of therapeutic effects between medium cut-off and high flux dialyzers using metabolomics and proteomics: exploratory, prospective study in hemodialysis.
Kim HJ; Seong EY; Lee W; Kim S; Ahn HS; Yeom J; Kim K; Kwon CH; Song SH
Sci Rep; 2021 Aug; 11(1):17335. PubMed ID: 34462546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
